FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JM Leonard

Research Profile

Chemicals & Drugs

Living Beings

HIV-1

Physiology

Concepts & Ideas

Disorders

HIV Infections

Procedures

Anatomy

Cell Line, Transformed

Co-author Network

Publications

TOP 3
M Louise Markert; Charles B Hicks; John A Bartlett; J L Harmon; Laura P Hale; ML Greenberg; Guido Ferrari; Janet Ottinger; A Boeck; A L Kloster; TM McLaughlin; KAREN BLEICH; R M Ungerleider; H Kim Lyerly; William E Wilkinson; Franck Rousseau; ME Heath-Chiozzi; JM Leonard; Ashley T Haase; George M Shaw; R Pat Bucy; D C Douek; Richard A Koup; Barton F Haynes; Dani P Bolognesi; Kent J Weinhold
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.
Jonathan Q Purnell; Alberto Zambon; Robert H Knopp; DJ Pizzuti; R Achari; JM Leonard; Charles S Locke; John D Brunzell
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.
William Cameron; Anthony J Japour; Y Xu; Ann Hsu; J Mellors; C Farthing; C Cohen; D Poretz; M Markowitz; S Follansbee; Jonathan B Angel; D McMahon; D Ho; V Devanarayan; Richard Rode; M Salgo; Dale J Kempf; Richard G Granneman; JM Leonard; Eugene Sun
Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JM Leonard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: M Louise Markert; Charles B Hicks; John A Bartlett; J L Harmon; Laura P Hale; ML Greenberg; Guido Ferrari; Janet Ottinger; A Boeck; A L Kloster; TM McLaughlin; KAREN BLEICH; R M Ungerleider; H Kim Lyerly; William E Wilkinson; Franck Rousseau; ME Heath-Chiozzi; JM Leonard; Ashley T Haase; George M Shaw; R Pat Bucy; D C Douek; Richard A Koup; Barton F Haynes; Dani P Bolognesi; Kent J Weinhold
Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.
AIDS research and human retroviruses 2000;16(5):403-13.
2000: Jonathan Q Purnell; Alberto Zambon; Robert H Knopp; DJ Pizzuti; R Achari; JM Leonard; Charles S Locke; John D Brunzell
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.
AIDS (London, England) 2000;14(1):51-7.
1999: William Cameron; Anthony J Japour; Y Xu; Ann Hsu; J Mellors; C Farthing; C Cohen; D Poretz; M Markowitz; S Follansbee; Jonathan B Angel; D McMahon; D Ho; V Devanarayan; Richard Rode; M Salgo; Dale J Kempf; Richard G Granneman; JM Leonard; Eugene Sun
Ritonavir and saquinavir combination therapy for the treatment of HIV infection.
AIDS (London, England) 1999;13(2):213-24.
1998: Hing L Sham; Dale J Kempf; Akhteruzzaman Molla; Kennan Marsh; Gondi N Kumar; Chih-Ming Chen; Warren M Kati; K Stewart; R Lal; Ann Hsu; David A Betebenner; M Korneyeva; Sudthida Vasavanonda; Edith McDonald; Ayda Saldivar; Norman E Wideburg; Xiaoqi Chen; P Niu; Chang Park; Venkata K Jayanti; Brian A Grabowski; G Richard Granneman; Eugene Sun; Anthony J Japour; JM Leonard; Jacob J Plattner; Daniel W Norbeck
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease.
Antimicrobial agents and chemotherapy 1998;42(12):3218-24.
1998: D Ouellet; Ann Hsu; J Qian; J E Lamm; John H Cavanaugh; JM Leonard; G Richard Granneman
Effect of fluoxetine on pharmacokinetics of ritonavir.
Antimicrobial agents and chemotherapy 1998;42(12):3107-12.
1998: Ann Hsu; G Richard Granneman; Guoliang Cao; L Carothers; Anthony J Japour; Tawakol A El-Shourbagy; S Dennis; J Berg; Keith Erdman; JM Leonard; Eugene Sun
Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers.
Antimicrobial agents and chemotherapy 1998;42(11):2784-91.
1998: Akhteruzzaman Molla; Sudthida Vasavanonda; G Kumar; Hing L Sham; M Johnson; Brian A Grabowski; Jon F Denissen; William Kohlbrenner; Jacob J Plattner; JM Leonard; Daniel W Norbeck; Dale J Kempf
Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus.
Virology 1998;250(2):255-62.
1998: D Ouellet; Ann Hsu; G Richard Granneman; G Carlson; J Cavanaugh; HJ Guenther; JM Leonard
Pharmacokinetic interaction between ritonavir and clarithromycin.
Clinical pharmacology and therapeutics 1998;64(4):355-62.
1998: A Carrillo; Kent D Stewart; Hing L Sham; Daniel W Norbeck; William Kohlbrenner; JM Leonard; Dale J Kempf; Akhteruzzaman Molla
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor.
Journal of virology 1998;72(9):7532-41.
1998: D Ouellet; Ann Hsu; J Qian; Charles S Locke; C J Eason; John H Cavanaugh; JM Leonard; G Richard Granneman
Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
British journal of clinical pharmacology 1998;46(2):111-6.
1998: P S Eastman; J Mittler; R Kelso; C Gee; E Boyer; Janice A Kolberg; MS Urdea; JM Leonard; Daniel W Norbeck; Hongmei Mo; M Markowitz
Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapy.
Journal of virology 1998;72(6):5154-64.
1998: Ann Hsu; G Richard Granneman; Guoliang Cao; L Carothers; Tawakol A El-Shourbagy; PA Baroldi; Keith Erdman; F Brown; Eugene Sun; JM Leonard
Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.
Clinical pharmacology and therapeutics 1998;63(4):453-64.
1998: Jonathan B Angel; Ashok Kumar; Karl G Parato; Lionel G Filion; Francisco Diaz-Mitoma; Pirouz Daftarian; B Pham; Eugene Sun; JM Leonard; William Cameron
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir.
The Journal of infectious diseases 1998;177(4):898-904.
1998: Dale J Kempf; Richard Rode; Y Xu; Eugene Sun; ME Heath-Chiozzi; J Valdes; Anthony J Japour; S Danner; C Boucher; Akhteruzzaman Molla; JM Leonard
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir.
AIDS (London, England) 1998;12(5):F9-14.
1997: Ann Hsu; G Richard Granneman; GF Witt; Charles S Locke; Jon F Denissen; Akhteruzzaman Molla; J Valdes; J Smith; Keith Erdman; N Lyons; P Niu; JP Decourt; JB Fourtillan; J Girault; JM Leonard
Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects.
Antimicrobial agents and chemotherapy 1997;41(5):898-905.
1997: Dale J Kempf; Kennan Marsh; G Kumar; A David Rodrigues; Jon F Denissen; Edith McDonald; M J Kukulka; Ann Hsu; G Richard Granneman; PA Baroldi; Eugene Sun; DJ Pizzuti; Jacob J Plattner; Daniel W Norbeck; JM Leonard
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.
Antimicrobial agents and chemotherapy 1997;41(3):654-60.